Home » IOMAI Receives $2.9 Million Grant From NIH for Patch Technology
IOMAI Receives $2.9 Million Grant From NIH for Patch Technology
IOMAI, a private biopharmaceutical company, has announced the award of a $2.9
million grant from NIH to help develop a patch that is designed to improve responses
to influenza vaccination. The grant, titled "Immunostimulatory Patch to
Enhance Biodefense Vaccines," was made under the National Institute for
Allergy and Infectious Disease program, "Cooperative Research for the Development
of Vaccines, Adjuvants, Therapeutics, Immunotherapeutics, and Diagnostics for
Biodefense and SARS."
Business
Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May